Article
Discovery of Canine Drug Toceranib Phosphate as a Repurposed Agent against Human Hepatocellular Carcinoma
2022-01-31
Abstract excerpt
<h4>Background: </h4> Human hepatocellular carcinoma (HCC) is an aggressive malignancy worldwide with a poor clinical outcome. There are limited therapeutic options currently available for those diagnosed with terminal HCC and therefore incorporating novel agents into standard-of-care regimens is urgently needed. In contrast to de novo drug discovery, the strategy of repurposing already-approved compounds initiall...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 245ac3df-7367-5aa8-9984-762b3c3ce638
- DOI
- 10.21203/rs.3.rs-1298194/v1
